β
Outcome MeasureOther

SF-MPQ

Short Form McGill Pain Questionnaire

2 Papers in Blossom

Outcome Data Across Studies

Reported results for SF-MPQ across 2 studies with quantitative data.

Outcome data across 3 study arm–timepoint observations
SD
Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, proof-of-concept clinical trial
2024Secondary
Oral Psilocybin + Therapy(experimental)05———
Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, proof-of-concept clinical trial
2024Secondary
Oral Psilocybin + Therapy(experimental)605———
Pilot study of psilocybin in patients with post-treatment lyme disease
2026Secondary
Psilocybin(experimental)020———

Papers Using SF-MPQ

Open Accessindividual

Pilot study of psilocybin in patients with post-treatment lyme disease

In an open‑label, single‑arm pilot study of 20 patients with post‑treatment Lyme disease, two psilocybin sessions with psychological support produced significant, sustained reductions in symptom burden (40% decrease in GSQ‑30 at six months) and improvements in both physical and mental quality of life. The intervention was feasible and well-tolerated with no serious related adverse events, supporting further controlled trials of psilocybin‑assisted therapy for PTLD.

Published
Journal
Scientific Reports
Authors
Garcia-Romeu, A., Naudé, G. P., Rebman, A. W., So, S., Yaffe, A., Geithner, I., Kozero, E. A., Yang, T., Soloski, M. J., Aucott, J. N.
Open Accessindividual

Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, proof-of-concept clinical trial

In an open-label proof-of-concept trial (N=5), psilocybin-assisted therapy was well tolerated in adults with fibromyalgia, producing only transient elevations in blood pressure/heart rate and non-serious post-dose headaches. Participants showed clinically meaningful improvements in pain severity, pain interference and sleep disturbance one month after treatment, supporting progression to larger randomised controlled trials.

Published
Journal
Frontiers in Pain Research
Authors
Aday, J. S., Mcafee, J., Conroy, D. A., Hosanagar, A., Tarnal, V., Weston, C., Scott, K., Horowitz, D., Harte, S. E., Pouyan, N., Glynos, N. G., Baker, A. K., Guss, J., Davis, A. K., Burgess, H. J., Mashour, G. A., Clauw, D. J., Boehnke, K. F.

Quick Facts

Full Name
Short Form McGill Pain Questionnaire
Domain
Other
Papers Indexed
2
Score Range
0–45
Interpretation
Lower = better
All Measures